| Field | Row 1 | Row 2 | Row 3 |
|---|---|---|---|
| adsh | 0001213900-25-043698 | 0001213900-25-031576 | 0001213900-25-029490 |
| cik | 1901203 | 1901203 | 1901203 |
| name | IRON HORSE ACQUISITIONS CORP. | IRON HORSE ACQUISITIONS CORP. | IRON HORSE ACQUISITIONS CORP. |
| sic | 2000 | 2000 | 2000 |
| countryba | US | US | US |
| stprba | CA | CA | CA |
| cityba | TOLUCA LAKE | TOLUCA LAKE | TOLUCA LAKE |
| zipba | 91610 | 91610 | 91610 |
| bas1 | P.O. BOX 2506 | P.O. BOX 2506 | P.O. BOX 2506 |
| bas2 | |||
| baph | (310) 290-5383 | (310) 290-5383 | (310) 290-5383 |
| countryma | US | US | US |
| stprma | CA | CA | CA |
| cityma | TOLUCA LAKE | TOLUCA LAKE | TOLUCA LAKE |
| zipma | 91610 | 91610 | 91610 |
| mas1 | P.O. BOX 2506 | P.O. BOX 2506 | P.O. BOX 2506 |
| mas2 | |||
| countryinc | US | US | US |
| stprinc | DE | DE | DE |
| ein | 000000000 | 000000000 | 000000000 |
| former | |||
| changed | |||
| afs | 4-NON | 4-NON | 4-NON |
| wksi | 0 | 0 | 0 |
| fye | 1231 | 1231 | 1231 |
| form | 10-Q | S-4/A | S-4/A |
| period | 20250331 | 20241231 | 20241231 |
| fy | 2025 | ||
| fp | Q1 | ||
| filed | 20250515 | 20250414 | 20250407 |
| accepted | 2025-05-15 08:01:00.0 | 2025-04-14 16:19:00.0 | 2025-04-07 17:26:00.0 |
| prevrpt | 0 | 0 | 0 |
| detail | 1 | 1 | 1 |
| instance | ea0241893-10q_ironhorse_htm.xml | ea0224529-08_htm.xml | ea0224529-06_htm.xml |
| nciks | 1 | 2 | 2 |
| aciks | 2045656 | 2045656 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-031576 | 20231231 | Accrued Liabilities Current | 70810.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | 3283710.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 656977.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Change In Fair Value Of Overallotment Option Liability | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Common Stock Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Earnings Per Share Basic | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Earnings Per Share Basic | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-031576 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -309018.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Increase Decrease In Accounts Payable | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Liabilities And Stockholders Equity | 72796002.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20241231 | Net Income Loss | 1375819.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20241231 | Operating Costs And Expenses | 1709829.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Other Notes Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Other Notes Payable Current | 425013.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Related Party; | ||
| 0001213900-25-031576 | 20231231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20241231 | Payments Of Stock Issuance Costs | 141914.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Proceeds From Bank Debt | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Proceeds From Notes Payable | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Proceeds From Repayments Of Related Party Debt | -1014523.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stockholders Equity | 69000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20241231 | Stockholders Equity | 197.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20241231 | Stock Issued1 | 3.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20230930 | Stock Issued During Period Shares New Issues | 1932000.0000 | shares | 0 | us-gaap/2024 | Range= Maximum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares New Issues | 32200.0000 | shares | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; | ||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | -7714359.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | -2829574.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Accounts Payable Current | 87578.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20231231 | Assets | 69690134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Assets | 72796002.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 656977.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -309018.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Increase Decrease In Prepaid Insurance | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Offering Costs Included In Accrued Offering Costs | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Other Underwriting Expense | 2518500.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Payments Of Stock Issuance Costs | 115800.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Proceeds From Bank Debt | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Proceeds From Bank Debt | 229770.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Proceeds From Issuance Initial Public Offering | 68413500.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Proceeds From Issuance Of Private Placement | 2457000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Remeasurement Of Common Stock Subject To Possible Redemption | 7714359.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Sale Of Stock Number Of Private Placement Warrants | 2457000.0000 | shares | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20231231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20241231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20221231 | Stockholders Equity | 193.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | Includes an aggregate of 32,200 shares of common stock subject to forfeiture, at December 31, 2023, by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full (Note 6). | |
| 0001213900-25-029490 | 20231231 | Stockholders Equity | -2690006.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares Acquisitions | shares | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Shares Acquisitions | 200000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Founder Shares; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares New Issues | 9357000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares New Issues | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Other | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | USD | 4 | 0001213900-25-029490 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | 3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20231231 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Public Shares; | ||
| 0001213900-25-029490 | 20241231 | Temporary Equity Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 1709423.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | Excludes an aggregate of 32,200 shares of common stock subject to forfeiture, at December 31, 2023 by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full (Note 6). | |
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | 43470.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Common Stock Shares Issued | 1999200.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20241231 | Common Stock Value | 197.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Earnings Per Share Diluted | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-031576 | 20231231 | Increase Decrease In Accrued Income Taxes Payable | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Increase Decrease In Accrued Liabilities | 799.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -32323.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Liabilities And Stockholders Equity | 69690134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Liabilities Current | 861640.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Loans Payable Current | 229770.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Notes Payable Current | 557781.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-031576 | 20241231 | Offering Costs Included In Accrued Offering Costs | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20231231 | Other Prepaid Expense Current | 33157.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Other Prepaid Expense Current | 834.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Payments To Acquire Investments | 229770.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Proceeds From Issuance Of Private Placement | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Proceeds From Issuance Of Private Placement | 2457000.0000 | USD | 4 | us-gaap/2024 | Related Party Transaction= Sponsor; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001213900-25-031576 | 20241231 | Remeasurement Of Common Stock Subject To Possible Redemption | 2829574.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Sale Of Stock Number Of Private Placement Warrants | 2457000.0000 | shares | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20221231 | Shares Outstanding | 1932000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20221231 | Stockholders Equity | -200374.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-031576 | 20231231 | Stockholders Equity | 200.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stockholders Equity | -2690206.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20241231 | Stockholders Equity | 71838571.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20240131 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Stock; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | -2829571.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20221231 | Temporary Equity Carrying Amount Attributable To Parent | 69000000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 69000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 71829574.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 1764192.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | Excludes an aggregate of 32,200 shares of common stock subject to forfeiture, at December 31, 2023 by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full (Note 6). | |
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 275665.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Additional Paid In Capital | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20241231 | Change In Fair Value Of Overallotment Option Liability | -11135.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Issuance Of Representative Shares | 4.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Marketable Securities Noncurrent | 69000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Cash Provided By Used In Financing Activities | 69740177.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20231231 | Nonoperating Income Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Offering Costs Included In Accrued Offering Costs | 221914.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20241231 | Operating Income Loss | -1709829.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Other Prepaid Expense Current | 834.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Overallotment Liability | USD | 0 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Proceeds From Issuance Initial Public Offering | 69000000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0001213900-25-029490 | 20241231 | Proceeds From Issuance Of Private Placement | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Proceeds From Repayments Of Related Party Debt | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20221231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20221231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20241231 | Stockholders Equity | 71838571.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20230930 | Stock Issued During Period Shares New Issues | 943000.0000 | shares | 0 | us-gaap/2024 | Range= Minimum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Other | -3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Other | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | 2457000.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | 2457000.0000 | USD | 4 | 0001213900-25-029490 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | -5533319.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | -2181040.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | -3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 71829574.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20241231 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Class Of Stock= Public Shares; | ||
| 0001213900-25-029490 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 71429.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | 43470.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20231231 | Amortization Of Debt Discount Premium | -11301.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 454.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Earnings Per Share Basic | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Earnings Per Share Basic | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Earnings Per Share Diluted | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Increase Decrease In Accounts Payable | 87578.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Increase Decrease In Accrued Income Taxes Payable | 746314.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Increase Decrease In Accrued Liabilities | 799.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Liabilities | 5110189.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-029490 | 20241231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-029490 | 20241231 | Net Income Loss | 1375819.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20241231 | Notes Payable Current | 627781.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-029490 | 20241231 | Proceeds From Notes Payable | 425013.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Proceeds From Related Party Debt | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Remeasurement Of Common Stock Subject To Possible Redemption | 2829574.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20221231 | Shares Outstanding | 1932000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares New Issues | 32200.0000 | shares | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares Other | 32200.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20240131 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Stock; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value I Representative Shares Value | 4.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value I Representative Shares Value | USD | 4 | 0001213900-25-029490 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | -2829571.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20231231 | Temporary Equity Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 6900000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 275665.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20231231 | Change On Overallotment Liability | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Common Stock Shares Issued | 1999200.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Common Stock Value | 200.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Common Stock Value | 197.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Earnings Per Share Basic | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Earnings Per Share Basic | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Increase Decrease In Accrued Income Taxes Payable | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 33157.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Issuance Of Representative Shares | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Loans Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Loans Payable Current | 229770.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Net Cash Provided By Used In Investing Activities | -226432.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Net Income Loss | 1375819.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20231231 | Offering Costs Paid Via Promissory Notes | 632273.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20241231 | Offering Costs Paid Via Promissory Notes | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Other Prepaid Expense Current | 33157.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Payments To Acquire Investments | 229770.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Retained Earnings Accumulated Deficit | -4143958.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Stockholders Equity | -4143761.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares New Issues | 6900000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value I Representative Shares Value | USD | 4 | 0001213900-25-029490 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20211130 | Stock Issued During Period Value New Issues | 25000.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Common Stock; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20241231 | Taxes Payable Current | 746314.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 1764192.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-031576 | 20231231 | Accounts Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | 3283710.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Assets | 69690134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 3338.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20241231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20241231 | Liabilities | 5110189.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Liabilities Current | 2591689.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Marketable Securities Noncurrent | 72752485.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Net Income Loss | -308792.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Nonoperating Income Expense | 3832188.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Notes Payable Current | 627781.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-031576 | 20231231 | Other Underwriting Expense | 2518500.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Proceeds From Repayments Of Related Party Debt | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20221231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | Includes an aggregate of 32,200 shares of common stock subject to forfeiture, at December 31, 2023, by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full (Note 6). | ||
| 0001213900-25-031576 | 20241231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20221231 | Stockholders Equity | 193.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued1 | 3.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares Acquisitions | shares | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Shares Acquisitions | 200000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Founder Shares; | ||
| 0001213900-25-031576 | 20220930 | Stock Issued During Period Shares New Issues | 2875000.0000 | shares | 0 | us-gaap/2024 | Range= Maximum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-031576 | 20220930 | Stock Issued During Period Shares New Issues | 2875000.0000 | shares | 0 | us-gaap/2024 | Range= Minimum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Shares Share Based Compensation Forfeited | shares | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | -3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 71829574.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Redemption Price Per Share | 10.4100 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Public Shares; | ||
| 0001213900-25-031576 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 71429.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 1967000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Accrued Offering Costs Current | 75000.0000 | USD | 0 | 0001213900-25-029490 | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 656977.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Common Stock Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Remeasurement Of Common Stock Subject To Possible Redemption | 7714359.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Income Tax Expense Benefit | -226.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Increase Decrease In Accrued Liabilities | 329423.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Net Cash Provided By Used In Financing Activities | 582869.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Nonoperating Income Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Overallotment Liability | USD | 0 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20241231 | Prepaid Insurance | 42229.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Proceeds From Issuance Initial Public Offering | 69000000.0000 | USD | 4 | us-gaap/2024 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20241231 | Proceeds From Issuance Initial Public Offering | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Proceeds From Issuance Of Private Placement | 2457000.0000 | USD | 4 | us-gaap/2024 | Class Of Warrant Or Right= Private Placement Warrants; Related Party Transaction= Sponsor; | ||
| 0001213900-25-031576 | 20241231 | Proceeds From Related Party Debt | 70000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20221231 | Stockholders Equity | 24807.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-031576 | 20240131 | Stock Issued During Period Shares Other | 1932000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Related Party Transactions By Related Party= Founder Shares; | ||
| 0001213900-25-031576 | 20240131 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Stock; Related Party Transaction= Sponsor; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value I Representative Shares Value | 4.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value I Representative Shares Value | USD | 4 | 0001213900-25-031576 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value I Representative Shares Value | USD | 4 | 0001213900-25-031576 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value New Issues | 69000000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | 32200.0000 | USD | 4 | us-gaap/2024 | Class Of Stock= Common Stock; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-031576 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | -2181040.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20231231 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 6900000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 1709423.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | 43470.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -656523.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 3338.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20241231 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Common Stock Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Earnings Per Share Diluted | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Income Tax Expense Benefit | -226.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Increase Decrease In Accounts Payable | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Increase Decrease In Accrued Liabilities | 329423.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Lawsuit Settlements | 295000.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20241231 | Liabilities And Stockholders Equity | 72796002.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Other Noncash Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Payments Of Stock Issuance Costs | 141914.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Proceeds From Notes Payable | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Proceeds From Repayments Of Related Party Debt | -1014523.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Retained Earnings Accumulated Deficit | -2690206.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20221231 | Stockholders Equity | -200374.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-029490 | 20231231 | Stockholders Equity | 69000000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20231231 | Stockholders Equity | -2690206.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value New Issues | 69000000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-029490 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | -7714359.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | 2838568.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20221231 | Temporary Equity Carrying Amount Attributable To Parent | 69000000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 1967000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 6900000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 1967000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Additional Paid In Capital | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | 3283710.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | 3283710.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20241231 | Amortization Of Debt Discount Premium | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Assets Current | 690134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Assets Current | 43517.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Change In Fair Value Of Overallotment Option Liability | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Common Stock Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -32323.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Investment Income Interest | 3526053.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Liabilities | 3380140.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Liabilities Current | 2591689.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Marketable Securities Noncurrent | 72752485.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Cash Provided By Used In Investing Activities | -69000000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Cash Provided By Used In Operating Activities | -83200.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Income Loss | -308792.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20241231 | Nonoperating Income Expense | 3832188.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Other Notes Payable Current | 425013.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20221231 | Stockholders Equity | -175374.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Stockholders Equity | 200.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-029490 | 20241231 | Stockholders Equity | 197.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Stockholders Equity | -4143958.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Shares Acquisitions | 35000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20220930 | Stock Issued During Period Shares New Issues | 2875000.0000 | shares | 0 | us-gaap/2024 | Range= Minimum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-029490 | 20240131 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Stock; Related Party Transaction= Sponsor; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | USD | 4 | 0001213900-25-029490 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | 32200.0000 | USD | 4 | us-gaap/2024 | Class Of Stock= Common Stock; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-029490 | 20231231 | Taxes Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 69000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Redemption Price Per Share | 10.4100 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Accrued Offering Costs Current | 221914.0000 | USD | 0 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 275665.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | 43470.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20231231 | Amortization Of Debt Discount Premium | -11301.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Assets | 72796002.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 454.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Change In Fair Value Of Overallotment Option Liability | -11135.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Common Stock Shares Issued | 1999200.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2024 | At December 31, 2023, includes an aggregate of 32,200 Founder Shares subject to forfeiture by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full. On February 12, 2024, the remainder of the over-allotment option to purchase 115,000 Units expired and 32,200 Founder Shares were forfeited, resulting in the Sponsor holding an aggregate of 1,932,000 Founder Shares (Note 6). | ||
| 0001213900-25-031576 | 20241231 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 2122359.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Issuance Of Representative Shares | 4.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Loans Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20231231 | Offering Costs Included In Accrued Offering Costs | 221914.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Operating Costs And Expenses | 309018.0000 | USD | 4 | us-gaap/2024 | For the year ended December 31, 2024 and 2023, includes $168,658 and $5,382 franchise tax expense, respectively. | ||
| 0001213900-25-031576 | 20241231 | Operating Income Loss | -1709829.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Other Noncash Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Other Underwriting Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Payments Of Stock Issuance Costs | 115800.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Proceeds From Issuance Initial Public Offering | 69000000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-031576 | 20231231 | Proceeds From Issuance Of Private Placement | 2457000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Proceeds From Related Party Debt | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20221231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Stockholders Equity | -2690006.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Stockholders Equity | -4143761.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20230930 | Stock Issued During Period Shares New Issues | 943000.0000 | shares | 0 | us-gaap/2024 | Range= Minimum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares New Issues | 6900000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-031576 | 20211130 | Stock Issued During Period Value New Issues | 25000.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Other | -3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | 2457000.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | 2457000.0000 | USD | 4 | 0001213900-25-031576 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | USD | 4 | 0001213900-25-031576 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20241231 | Taxes Payable Current | 746314.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Temporary Equity Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 71429.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 1967000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Accrued Liabilities Current | 70810.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Accrued Liabilities Current | 400233.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 656977.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-029490 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Subsidiary Sale Of Stock= I P O; | ||
| 0001213900-25-029490 | 20241231 | Earnings Per Share Diluted | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Income Tax Expense Benefit | 746540.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Increase Decrease In Accrued Offering Costs | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20241231 | Increase Decrease In Accrued Offering Costs | -5000.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Investment Income Interest | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Lawsuit Settlements | USD | 4 | 0001213900-25-029490 | ||||
| 0001213900-25-029490 | 20231231 | Net Income Loss | -308792.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20241231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20231231 | Operating Costs And Expenses | 309018.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Operating Costs And Expenses | 1709829.0000 | USD | 4 | us-gaap/2024 | For the year ended December 31, 2024 and 2023, includes $168,658 and $5,382 franchise tax expense, respectively. | ||
| 0001213900-25-029490 | 20231231 | Operating Income Loss | -309018.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Other Notes Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Prepaid Insurance | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Prepaid Insurance | 42229.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Proceeds From Issuance Initial Public Offering | 69000000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-029490 | 20231231 | Proceeds From Issuance Initial Public Offering | 69000000.0000 | USD | 4 | us-gaap/2024 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-029490 | 20241231 | Proceeds From Issuance Initial Public Offering | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Proceeds From Issuance Of Private Placement | 2457000.0000 | USD | 4 | us-gaap/2024 | Class Of Warrant Or Right= Private Placement Warrants; Related Party Transaction= Sponsor; | ||
| 0001213900-25-029490 | 20241231 | Proceeds From Issuance Of Private Placement | 2457000.0000 | USD | 4 | us-gaap/2024 | Related Party Transaction= Sponsor; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001213900-25-029490 | 20221231 | Stockholders Equity | 24807.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-029490 | 20211130 | Stock Issued During Period Shares New Issues | 5750000.0000 | shares | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Common Stock; | ||
| 0001213900-25-029490 | 20220930 | Stock Issued During Period Shares New Issues | 2875000.0000 | shares | 0 | us-gaap/2024 | Range= Maximum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value I Representative Shares Value | USD | 4 | 0001213900-25-029490 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value I Representative Shares Value | 4.0000 | USD | 4 | 0001213900-25-029490 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Other | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Stock Issued During Period Value Other | 3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | -3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20241231 | Accounts Payable Current | 87578.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Additional Paid In Capital | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Additional Paid In Capital | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Assets Current | 690134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -656523.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Change On Overallotment Liability | 11135.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20241231 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20241231 | Earnings Per Share Basic | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20231231 | Earnings Per Share Diluted | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Increase Decrease In Accounts Payable | 87578.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Increase Decrease In Prepaid Insurance | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Increase Decrease In Prepaid Insurance | 42229.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Lawsuit Settlements | 295000.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Net Cash Provided By Used In Financing Activities | 69740177.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Net Cash Provided By Used In Operating Activities | -1012960.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-031576 | 20231231 | Net Income Loss | -308792.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20241231 | Net Income Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-031576 | 20231231 | Other Noncash Expense | 269251.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Overallotment Liability | 11135.0000 | USD | 0 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Payments To Acquire Investments | 69000000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Retained Earnings Accumulated Deficit | -2690206.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares New Issues | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value I Representative Shares Value | USD | 4 | 0001213900-25-031576 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Other | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Other | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | -3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | 2838568.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20241231 | Accrued Offering Costs Current | 75000.0000 | USD | 0 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -477654.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20240331 | Earnings Per Share Basic | 0.0500 | USD | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 232971.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Liabilities | 5110189.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Net Cash Provided By Used In Investing Activities | 3337.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Net Income Loss | 473415.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Net Income Loss | 83760.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20241231 | Notes Payable Current | 627781.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-043698 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Remeasurement Of Common Stock Subject To Possible Redemption | -597362.0000 | USD | 1 | 0001213900-25-043698 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20241231 | Retained Earnings Accumulated Deficit | -4143958.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20231231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20240331 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | Includes an aggregate of 32,200 shares of common stock subject to forfeiture, at December 31, 2023 by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full. On December 29, 2023, the underwriters partially exercised their over-allotment option for an additional 800,000 Units, reducing the Founder Shares subject to forfeiture to 32,200. On February 12, 2024, the remainder of the over-allotment option to purchase 115,000 Units expired and the 32,200 Founde | |
| 0001213900-25-043698 | 20241231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043698 | 20240331 | Stockholders Equity | -2813956.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Stockholders Equity | -2814153.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 72620412.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 72620412.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20241231 | Temporary Equity Redemption Price Per Share | 10.4100 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Temporary Equity Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 1967000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 1967000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20241231 | Accounts Payable Current | 87578.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 275665.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20231231 | Change On Overallotment Liability | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Earnings Per Share Basic | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Earnings Per Share Diluted | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Income Tax Expense Benefit | 746540.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 33157.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Investment Income Interest | 3526053.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Issuance Of Representative Shares | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20231231 | Marketable Securities Noncurrent | 69000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Offering Costs Paid Via Promissory Notes | 632273.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20241231 | Other Notes Payable Current | 425013.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Proceeds From Issuance Initial Public Offering | 69000000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0001213900-25-031576 | 20231231 | Proceeds From Issuance Initial Public Offering | 68413500.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Proceeds From Notes Payable | 425013.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Retained Earnings Accumulated Deficit | -4143958.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20221231 | Stockholders Equity | -175374.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Stockholders Equity | -4143958.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares Acquisitions | 35000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares Other | 32200.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Other | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Sale Of Private Placement Warrants | USD | 4 | 0001213900-25-031576 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | 3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20231231 | Taxes Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | -5533319.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-031576 | 20241231 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2024 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Class Of Stock= Public Shares; | ||
| 0001213900-25-043698 | 20250331 | Additional Paid In Capital | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Assets | 73647206.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 179323.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 88.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20241231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-043698 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Subsidiary Sale Of Stock= I P O; | ||
| 0001213900-25-043698 | 20240331 | Earnings Per Share Diluted | 0.0500 | USD | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Earnings Per Share Diluted | 0.0100 | USD | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20240331 | Gain On Lawsuit Settlements | 295000.0000 | USD | 1 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 142679.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 147192.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -7243.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Increase Decrease In Prepaid Insurance | -42229.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Investment Income Interest | 858253.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Net Cash Provided By Used In Financing Activities | 471041.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Net Cash Provided By Used In Investing Activities | -62120.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Net Cash Provided By Used In Operating Activities | -374077.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Net Cash Provided By Used In Operating Activities | -409287.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Other Prepaid Expense Current | 834.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Proceeds From Related Party Debt | 229770.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Remeasurement Of Common Stock Subject To Possible Redemption | -790838.0000 | USD | 1 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043698 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043698 | 20250331 | Stockholders Equity | 197.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20250331 | Stockholders Equity | 72620412.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20231231 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2025 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-043698 | 20250331 | Accounts Payable Current | 273703.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Accrued Liabilities Current | 400233.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Additional Paid In Capital | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20241231 | Assets Current | 43517.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Assets Current | 79672.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Change In Fair Value Of Overallotment Option Liability | USD | 1 | 0001213900-25-043698 | ||||
| 0001213900-25-043698 | 20241231 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20250331 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Common Stock Value | 197.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Earnings Per Share Basic | 0.0100 | USD | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20240331 | Income Tax Expense Benefit | 211115.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Increase Decrease In Due From Related Parties | 206500.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Marketable Securities Noncurrent | 72752485.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Notes Payable Current | 857551.0000 | USD | 0 | us-gaap/2025 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-043698 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20240331 | Proceeds From Related Party Debt | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Promissory Note Related Party | 857551.0000 | USD | 0 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20250331 | Remeasurement Of Common Stock Subject To Possible Redemption | USD | 1 | 0001213900-25-043698 | Equity Components= Common Stock; | |||
| 0001213900-25-043698 | 20231231 | Stockholders Equity | 200.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043698 | 20241231 | Stockholders Equity | 197.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20241231 | Stockholders Equity | 71829574.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20240131 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Stock; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-043698 | 20250331 | Taxes Payable Current | 895525.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 6900000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6900000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20241231 | Assets | 72796002.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 656977.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Liabilities | 5877633.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 454.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20240331 | Increase Decrease In Accrued Income Taxes Payable | 210889.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Increase Decrease In Due From Related Parties | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Liabilities Current | 3359133.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Loans Payable Current | 229770.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Prepaid Insurance | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Remeasurement Of Common Stock Subject To Possible Redemption | USD | 1 | 0001213900-25-043698 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-043698 | 20231231 | Shares Outstanding | 1999200.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20240331 | Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20231231 | Stockholders Equity | -2690006.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20231231 | Stockholders Equity | 69000000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20241231 | Stockholders Equity | -4143761.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Stockholders Equity | -4851036.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20240331 | Stock Issued During Period Value Share Based Compensation Forfeited | -3.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043698 | 20250331 | Temporary Equity Redemption Price Per Share | 10.5200 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Accrued Liabilities Current | 361300.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -366.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20250331 | Common Stock Value | 197.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Earnings Per Share Basic | 0.0500 | USD | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Earnings Per Share Basic | 0.0100 | USD | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Increase Decrease In Accrued Income Taxes Payable | 149211.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 78750.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Investment Income Interest | 752929.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Net Cash Provided By Used In Financing Activities | -106914.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Net Income Loss | 83760.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Nonoperating Income Expense | 1164388.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Payments To Acquire Investments | 229770.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Promissory Note Related Party | 627781.0000 | USD | 0 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20240331 | Remeasurement Of Common Stock Subject To Possible Redemption | -597365.0000 | USD | 1 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20250331 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20231231 | Stockholders Equity | -2690206.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20240331 | Stockholders Equity | 197.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20240331 | Stockholders Equity | 69597365.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20240331 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-043698 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 69000000.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 71829574.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Earnings Per Share Diluted | 0.0500 | USD | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Earnings Per Share Diluted | 0.0100 | USD | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 684530.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Income Tax Expense Benefit | 149211.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Liabilities Current | 2591689.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Other Prepaid Expense Current | 79584.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Payments To Acquire Investments | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20250331 | Proceeds From Notes Payable | 316271.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Retained Earnings Accumulated Deficit | -4851036.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20241231 | Stockholders Equity | -4143958.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20240331 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20240331 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20240331 | Stock Issued During Period Value Share Based Compensation Forfeited | 3.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20250331 | Stock Issued During Period Value Share Based Compensation Forfeited | 32200.0000 | USD | 1 | us-gaap/2025 | Class Of Stock= Common Stock; Subsidiary Sale Of Stock= Over Allotment Option; | ||
| 0001213900-25-043698 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 71829574.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 1967000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 1967000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-043698 | 20240331 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 3337.0000 | USD | 1 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20250331 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 167650.0000 | USD | 1 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20240331 | Change In Fair Value Of Overallotment Option Liability | 11135.0000 | USD | 1 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Increase Decrease In Prepaid Insurance | 132415.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Liabilities And Stockholders Equity | 73647206.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Marketable Securities Noncurrent | 72752485.0000 | USD | 0 | us-gaap/2025 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001213900-25-043698 | 20250331 | Marketable Securities Noncurrent | 73567534.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Net Income Loss | 473415.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20241231 | Notes Payable Current | 425013.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Operating Costs And Expenses | 479858.0000 | USD | 1 | us-gaap/2025 | Includes $42,400 and $50,657 franchise tax expense for the three months ended March 31, 2025 and 2024, respectively. | ||
| 0001213900-25-043698 | 20240331 | Payments Of Stock Issuance Costs | 106914.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Payments Of Stock Issuance Costs | 75000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Remeasurement Of Common Stock Subject To Possible Redemption | USD | 1 | 0001213900-25-043698 | Equity Components= Common Stock; | |||
| 0001213900-25-043698 | 20241231 | Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-043698 | 20250331 | Stockholders Equity | -4850839.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2025 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Class Of Stock= Public Shares; | ||
| 0001213900-25-043698 | 20250331 | Temporary Equity Redemption Price Per Share | 10.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Public Shares; | ||
| 0001213900-25-043698 | 20250331 | Temporary Equity Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6900000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6900000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-029490 | 20231231 | Accounts Payable Current | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Accrued Offering Costs Current | 221914.0000 | USD | 0 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-029490 | 20241231 | Change On Overallotment Liability | 11135.0000 | USD | 4 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | At December 31, 2023, includes an aggregate of 32,200 Founder Shares subject to forfeiture by the initial stockholder to the extent that the underwriters over-allotment option is not exercised in full. On February 12, 2024, the remainder of the over-allotment option to purchase 115,000 Units expired and 32,200 Founder Shares were forfeited, resulting in the Sponsor holding an aggregate of 1,932,000 Founder Shares (Note 6). | ||
| 0001213900-25-029490 | 20231231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Common Stock Shares Issued | 1999200.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Common Stock Shares Issued | 1967000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Common Stock Shares Outstanding | 1967000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-029490 | 20241231 | Earnings Per Share Diluted | 0.1600 | USD | 4 | us-gaap/2024 | Class Of Stock= Non Redeemable Shares; | ||
| 0001213900-25-029490 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 2122359.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Increase Decrease In Prepaid Insurance | 42229.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Liabilities And Stockholders Equity | 69690134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Liabilities Current | 861640.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Net Cash Provided By Used In Financing Activities | 582869.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Net Cash Provided By Used In Operating Activities | -1012960.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Notes Payable Current | 557781.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001213900-25-029490 | 20231231 | Other Noncash Expense | 269251.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Other Notes Payable Current | 425013.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Related Party; | ||
| 0001213900-25-029490 | 20241231 | Other Underwriting Expense | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Overallotment Liability | 11135.0000 | USD | 0 | 0001213900-25-029490 | |||
| 0001213900-25-029490 | 20231231 | Payments To Acquire Investments | 69000000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20241231 | Proceeds From Related Party Debt | 70000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Stock Issued1 | 3.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Stock Issued1 | 3.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20230930 | Stock Issued During Period Shares New Issues | 1932000.0000 | shares | 0 | us-gaap/2024 | Range= Maximum; Related Party Transaction= Founder Shares; | ||
| 0001213900-25-029490 | 20240131 | Stock Issued During Period Shares Other | 1932000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Related Party Transactions By Related Party= Founder Shares; | ||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Shares Share Based Compensation Forfeited | shares | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20241231 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-029490 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | -2829574.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 71829574.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-029490 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 71429.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Accrued Liabilities Current | 400233.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Accrued Offering Costs Current | 75000.0000 | USD | 0 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | USD | 4 | us-gaap/2024 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-031576 | 20231231 | Adjustments To Additional Paid In Capital Mark To Market | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001213900-25-031576 | 20241231 | Amortization Of Debt Discount Premium | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Assets Current | 43517.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20231231 | Common Stock Value | 200.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-031576 | Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Subsidiary Sale Of Stock= I P O; | ||
| 0001213900-25-031576 | 20231231 | Earnings Per Share Diluted | -0.1700 | USD | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-031576 | 20241231 | Increase Decrease In Accrued Income Taxes Payable | 746314.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Increase Decrease In Accrued Offering Costs | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20241231 | Increase Decrease In Accrued Offering Costs | -5000.0000 | USD | 4 | 0001213900-25-031576 | |||
| 0001213900-25-031576 | 20231231 | Investment Income Interest | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Lawsuit Settlements | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20231231 | Liabilities | 3380140.0000 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Net Cash Provided By Used In Investing Activities | -69000000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Net Cash Provided By Used In Investing Activities | -226432.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Net Cash Provided By Used In Operating Activities | -83200.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Net Income Loss | 1375819.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Offering Costs Paid Via Promissory Notes | USD | 4 | 0001213900-25-031576 | ||||
| 0001213900-25-031576 | 20231231 | Operating Income Loss | -309018.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20231231 | Prepaid Insurance | USD | 0 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20241231 | Proceeds From Bank Debt | 229770.0000 | USD | 4 | us-gaap/2024 | |||
| 0001213900-25-031576 | 20211130 | Stock Issued During Period Shares New Issues | 5750000.0000 | shares | 0 | us-gaap/2024 | Related Party Transaction= Founder Shares; Subsidiary Sale Of Stock= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Shares New Issues | 9357000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value I Representative Shares Value | 4.0000 | USD | 4 | 0001213900-25-031576 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | ||||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value New Issues | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-031576 | 20231231 | Stock Issued During Period Value Other | 3.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001213900-25-031576 | 20231231 | Temporary Equity Accretion To Redemption Value Adjustment | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20241231 | Temporary Equity Accretion To Redemption Value Adjustment | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001213900-25-031576 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 6900000.0000 | shares | 4 | us-gaap/2024 | Class Of Stock= Redeemable Shares; | ||
| 0001213900-25-043698 | 20250331 | Accrued Offering Costs Current | USD | 0 | 0001213900-25-043698 | ||||
| 0001213900-25-043698 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20241231 | Deferred Underwriting Fee Payable | 2518500.0000 | USD | 0 | 0001213900-25-043698 | |||
| 0001213900-25-043698 | 20250331 | Gain On Lawsuit Settlements | USD | 1 | 0001213900-25-043698 | ||||
| 0001213900-25-043698 | 20241231 | Liabilities And Stockholders Equity | 72796002.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241130 | Loans Payable Current | 229770.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Loans Payable Current | 229770.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Marketable Securities Noncurrent | 73567534.0000 | USD | 0 | us-gaap/2025 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001213900-25-043698 | 20250331 | Nonoperating Income Expense | 752929.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Notes Payable Current | 741284.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Operating Costs And Expenses | 519958.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Operating Income Loss | -479858.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20250331 | Operating Income Loss | -519958.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Prepaid Insurance | 42229.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20240331 | Proceeds From Notes Payable | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-043698 | 20240331 | Remeasurement Of Common Stock Subject To Possible Redemption | -3.0000 | USD | 1 | 0001213900-25-043698 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-043698 | 20240331 | Remeasurement Of Common Stock Subject To Possible Redemption | 597365.0000 | USD | 1 | 0001213900-25-043698 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20250331 | Remeasurement Of Common Stock Subject To Possible Redemption | 790838.0000 | USD | 1 | 0001213900-25-043698 | Equity Components= Common Stock Subject To Possible Redemption; | ||
| 0001213900-25-043698 | 20250331 | Remeasurement Of Common Stock Subject To Possible Redemption | -790838.0000 | USD | 1 | 0001213900-25-043698 | Equity Components= Retained Earnings; | ||
| 0001213900-25-043698 | 20240131 | Stock Issued During Period Shares Share Based Compensation Forfeited | 32200.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Stock; Related Party Transaction= Sponsor; | ||
| 0001213900-25-043698 | 20240331 | Stock Issued During Period Value Share Based Compensation Forfeited | USD | 1 | us-gaap/2025 | Equity Components= Common Stock Subject To Possible Redemption; | |||
| 0001213900-25-043698 | 20240331 | Taxes Payable Current | 210889.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-043698 | 20241231 | Taxes Payable Current | 746314.0000 | USD | 0 | us-gaap/2025 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Temporary Equity Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Temporary Equity, Shares Outstanding | The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Amortization Of Debt Discount Premium | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. |
| Offering Costs Included In Accrued Offering Costs | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Offering Costs Included In Accrued Offering Costs | The amount of offering costs included in accrued offering costs. |
| Taxes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Taxes Payable, Current | Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Noncash Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Noncash Expense | Amount of expense or loss included in net income that result in no cash flow, classified as other. |
| Prepaid Insurance | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Insurance | Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Proceeds From Issuance Of Private Placement | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Stock Issued1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued | The fair value of stock issued in noncash financing activities. |
| Investment Income Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Other Prepaid Expense Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Prepaid Expense, Current | Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Stock Issued During Period Shares Share Based Compensation Forfeited | us-gaap/2025 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited | Number of shares (or other type of equity) forfeited during the period. | |
| Stock Issued During Period Value Share Based Compensation Forfeited | us-gaap/2025 | 0 | 0 | monetary | D | D | Shares Issued, Value, Share-Based Payment Arrangement, Forfeited | Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Temporary Equity Redemption Price Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Temporary Equity, Redemption Price Per Share | Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Gain On Lawsuit Settlements | 0001213900-25-043698 | 1 | 0 | monetary | D | C | Gain On Lawsuit Settlements | The amount of gain on law suit settlements. |
| Increase Decrease In Accrued Offering Costs | 0001213900-25-029490 | 1 | 0 | monetary | D | D | Increase Decrease In Accrued Offering Costs | Represents the amount of accrued offering costs. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Payments To Acquire Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Proceeds From Bank Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Bank Debt | The cash inflow from bank borrowing during the year. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001213900-25-029490 | 1 | 0 | monetary | D | D | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | The amount of cash withdrawn from trust account to pay franchise and income taxes. |
| Deferred Underwriting Fee Payable | 0001213900-25-031576 | 1 | 0 | monetary | I | C | Deferred Underwriting Fee Payable | Amount of deferred underwriting fee payable. |
| Accrued Offering Costs Current | 0001213900-25-043698 | 1 | 0 | monetary | I | C | Accrued Offering Costs Current | Accrued offering costs. |
| Proceeds From Related Party Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Proceeds From Notes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Notes Payable | The cash inflow from a borrowing supported by a written promise to pay an obligation. |
| Stock Issued During Period Shares Share Based Compensation Forfeited | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited | Number of shares (or other type of equity) forfeited during the period. | |
| Accrued Offering Costs Current | 0001213900-25-029490 | 1 | 0 | monetary | I | C | Accrued Offering Costs Current | Accrued offering costs. |
| Lawsuit Settlements | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Lawsuit Settlements | Lawsuit settlements. |
| Stock Issued During Period Value I Representative Shares Value | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Stock Issued During Period Value IRepresentative Shares Value | Issuance of Representative Shares. |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Other Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Notes Payable, Current | Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Marketable Securities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Marketable Securities, Noncurrent | Amount of investment in marketable security, classified as noncurrent. |
| Operating Costs And Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
| Payments Of Stock Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Remeasurement Of Common Stock Subject To Possible Redemption | The amount of remeasurement of common stock subject to possible redemption. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Accrued Offering Costs Current | 0001213900-25-031576 | 1 | 0 | monetary | I | C | Accrued Offering Costs Current | Accrued offering costs. |
| Offering Costs Included In Accrued Offering Costs | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Offering Costs Included In Accrued Offering Costs | The amount of offering costs included in accrued offering costs. |
| Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001213900-25-043698 | 1 | 0 | monetary | D | D | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | The amount of cash withdrawn from trust account to pay franchise and income taxes. |
| Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-043698 | 1 | 0 | monetary | D | C | Remeasurement Of Common Stock Subject To Possible Redemption | The amount of remeasurement of common stock subject to possible redemption. |
| Increase Decrease In Prepaid Insurance | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Insurance | Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods. |
| Loans Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Loans Payable, Current | Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2025 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Deferred Underwriting Fee Payable | 0001213900-25-043698 | 1 | 0 | monetary | I | C | Deferred Underwriting Fee Payable | Amount of deferred underwriting fee payable. |
| Issuance Of Representative Shares | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Issuance Of Representative Shares | Issuance of representative shares. |
| Change On Overallotment Liability | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Change On Overallotment Liability | Change on overallotment liability. |
| Increase Decrease In Accrued Offering Costs | 0001213900-25-031576 | 1 | 0 | monetary | D | D | Increase Decrease In Accrued Offering Costs | Represents the amount of accrued offering costs. |
| Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Remeasurement Of Common Stock Subject To Possible Redemption | The amount of remeasurement of common stock subject to possible redemption. |
| Deferred Underwriting Fee Payable | 0001213900-25-029490 | 1 | 0 | monetary | I | C | Deferred Underwriting Fee Payable | Amount of deferred underwriting fee payable. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Underwriting Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Underwriting Expense | Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts. |
| Proceeds From Issuance Initial Public Offering | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance Initial Public Offering | The cash inflow associated with the amount received from entity's first offering of stock to the public. |
| Stock Issued During Period Shares Other | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
| Temporary Equity Redemption Price Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Temporary Equity, Redemption Price Per Share | Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Temporary Equity Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Outstanding | The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Notes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Prepaid Insurance | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Insurance | Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Issuance Of Representative Shares | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Issuance Of Representative Shares | Issuance of representative shares. |
| Sale Of Stock Number Of Private Placement Warrants | 0001213900-25-031576 | 1 | 0 | shares | D | Sale Of Stock Number Of Private Placement Warrants | Number of sale of private placement warrants. | |
| Promissory Note Related Party | 0001213900-25-043698 | 1 | 0 | monetary | I | C | Promissory Note Related Party | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Overallotment Liability | 0001213900-25-031576 | 1 | 0 | monetary | I | C | Overallotment Liability | Amount of overallotment liability. |
| Marketable Securities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Noncurrent | Amount of investment in marketable security, classified as noncurrent. |
| Proceeds From Repayments Of Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Repayments of) Related Party Debt | Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Loans Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Loans Payable, Current | Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer. |
| Change In Fair Value Of Overallotment Option Liability | 0001213900-25-029490 | 1 | 0 | monetary | D | D | Change In Fair Value Of Overallotment Option Liability | fair value of over-allotment option liability. |
| Change On Overallotment Liability | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Change On Overallotment Liability | Change on overallotment liability. |
| Stock Issued During Period Value I Representative Shares Value | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Stock Issued During Period Value IRepresentative Shares Value | Issuance of Representative Shares. |
| Change In Fair Value Of Overallotment Option Liability | 0001213900-25-043698 | 1 | 0 | monetary | D | C | Change In Fair Value Of Overallotment Option Liability | The amount of change in fair value of over-allotment option liability. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
| Other Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Prepaid Expense, Current | Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Stock Issued During Period Value Share Based Compensation Forfeited | us-gaap/2024 | 0 | 0 | monetary | D | D | Shares Issued, Value, Share-Based Payment Arrangement, Forfeited | Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Temporary Equity Accretion To Redemption Value Adjustment | us-gaap/2024 | 0 | 0 | monetary | D | D | Temporary Equity, Accretion to Redemption Value, Adjustment | Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Increase Decrease In Due From Related Parties | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Due from Related Parties | The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity. |
| Payments To Acquire Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Offering Costs Paid Via Promissory Notes | 0001213900-25-029490 | 1 | 0 | monetary | D | C | Offering Costs Paid Via Promissory Notes | The amount of offering costs paid via promissory notes. |
| Stock Issued During Period Value Sale Of Private Placement Warrants | 0001213900-25-029490 | 1 | 0 | monetary | D | D | Stock Issued During Period Value Sale Of Private Placement Warrants | Amount of sale of private placement warrants. |
| Adjustments To Additional Paid In Capital Mark To Market | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Fair Value | Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Change In Fair Value Of Overallotment Option Liability | 0001213900-25-031576 | 1 | 0 | monetary | D | D | Change In Fair Value Of Overallotment Option Liability | fair value of over-allotment option liability. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Notes Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Notes Payable | The cash inflow from a borrowing supported by a written promise to pay an obligation. |
| Overallotment Liability | 0001213900-25-029490 | 1 | 0 | monetary | I | C | Overallotment Liability | Amount of overallotment liability. |
| Sale Of Stock Number Of Private Placement Warrants | 0001213900-25-029490 | 1 | 0 | shares | D | Sale Of Stock Number Of Private Placement Warrants | Number of sale of private placement warrants. | |
| Lawsuit Settlements | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Lawsuit Settlements | Lawsuit settlements. |
| Offering Costs Paid Via Promissory Notes | 0001213900-25-031576 | 1 | 0 | monetary | D | C | Offering Costs Paid Via Promissory Notes | The amount of offering costs paid via promissory notes. |
| Stock Issued During Period Value Sale Of Private Placement Warrants | 0001213900-25-031576 | 1 | 0 | monetary | D | D | Stock Issued During Period Value Sale Of Private Placement Warrants | Amount of sale of private placement warrants. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Stock Issued During Period Shares Acquisitions | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Acquisitions | Number of shares of stock issued during the period pursuant to acquisitions. | |
| Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Increase Decrease In Prepaid Insurance | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Insurance | Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Taxes Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Taxes Payable, Current | Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001213900-25-031576 | 1 | 0 | monetary | D | D | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | The amount of cash withdrawn from trust account to pay franchise and income taxes. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-031576 | 2 | 10 | BS | 0 | H | Prepaid Insurance | us-gaap/2024 | Prepaid insurance | 0 |
| 0001213900-25-029490 | 2 | 8 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash | 0 |
| 0001213900-25-029490 | 2 | 9 | BS | 0 | H | Other Prepaid Expense Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-029490 | 2 | 10 | BS | 0 | H | Prepaid Insurance | us-gaap/2024 | Prepaid insurance | 0 |
| 0001213900-25-029490 | 2 | 11 | BS | 0 | H | Assets Current | us-gaap/2024 | Total Current Assets | 0 |
| 0001213900-25-029490 | 2 | 12 | BS | 0 | H | Marketable Securities Noncurrent | us-gaap/2024 | Marketable securities held in Trust Account | 0 |
| 0001213900-25-029490 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001213900-25-029490 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001213900-25-029490 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001213900-25-029490 | 2 | 18 | BS | 0 | H | Accrued Offering Costs Current | 0001213900-25-029490 | Accrued offering costs | 0 |
| 0001213900-25-029490 | 2 | 19 | BS | 0 | H | Taxes Payable Current | us-gaap/2024 | Income taxes payable | 0 |
| 0001213900-25-029490 | 2 | 20 | BS | 0 | H | Overallotment Liability | 0001213900-25-029490 | Overallotment liability | 0 |
| 0001213900-25-029490 | 2 | 21 | BS | 0 | H | Loans Payable Current | us-gaap/2024 | Loan payable | 0 |
| 0001213900-25-029490 | 2 | 22 | BS | 0 | H | Other Notes Payable Current | us-gaap/2024 | Promissory note | 0 |
| 0001213900-25-029490 | 2 | 23 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Promissory note related party | 0 |
| 0001213900-25-029490 | 2 | 24 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
| 0001213900-25-029490 | 2 | 25 | BS | 0 | H | Deferred Underwriting Fee Payable | 0001213900-25-029490 | Deferred underwriting fee payable | 0 |
| 0001213900-25-029490 | 2 | 26 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001213900-25-029490 | 2 | 27 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and Contingencies (Note 5) | 0 |
| 0001213900-25-029490 | 2 | 28 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Common stock subject to possible redemption, 6,900,000 shares at redemption value of $10.41 and $10.00 per share as of December 31, 2024 and 2023, respectively | 0 |
| 0001213900-25-029490 | 2 | 30 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 |
| 0001213900-25-029490 | 2 | 31 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value; 50,000,000 shares authorized, 1,967,000 and 1,999,200 shares issued and outstanding (excluding 6,900,000 shares subject to possible redemption) as of December 31, 2024 and 2023, respectively | 0 |
| 0001213900-25-029490 | 2 | 32 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001213900-25-029490 | 2 | 33 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001213900-25-029490 | 2 | 34 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders Deficit | 0 |
| 0001213900-25-029490 | 2 | 35 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders Deficit | 0 |
| 0001213900-25-029490 | 3 | 1 | BS | 1 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Common stock subject to possible redemption, shares at redemption value | 0 |
| 0001213900-25-029490 | 3 | 2 | BS | 1 | H | Temporary Equity Redemption Price Per Share | us-gaap/2024 | Common stock subject to possible redemption, shares at redemption value per share (in Dollars per share) | 0 |
| 0001213900-25-029490 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock par value (in Dollars per share) | 0 |
| 0001213900-25-029490 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001213900-25-029490 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001213900-25-029490 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-029490 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-029490 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001213900-25-029490 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001213900-25-029490 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001213900-25-029490 | 4 | 7 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Formation and operational costs | 0 |
| 0001213900-25-029490 | 4 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001213900-25-029490 | 4 | 10 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest earned on marketable securities held in Trust Account | 0 |
| 0001213900-25-029490 | 4 | 11 | IS | 0 | H | Change On Overallotment Liability | 0001213900-25-029490 | Change on overallotment liability | 0 |
| 0001213900-25-029490 | 4 | 12 | IS | 0 | H | Lawsuit Settlements | 0001213900-25-029490 | Lawsuit settlements | 0 |
| 0001213900-25-029490 | 4 | 13 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income | 0 |
| 0001213900-25-029490 | 4 | 14 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income (Loss) before provision for income taxes | 0 |
| 0001213900-25-029490 | 4 | 15 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 1 |
| 0001213900-25-029490 | 4 | 16 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0001213900-25-029490 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-029490 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-029490 | 4 | 19 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per common share (in Dollars per share) | 0 |
| 0001213900-25-029490 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per common share (in Dollars per share) | 0 |
| 0001213900-25-029490 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001213900-25-029490 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
| 0001213900-25-029490 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Issuance of founder shares | 0 |
| 0001213900-25-029490 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Issuance of founder shares (in Shares) | 0 |
| 0001213900-25-029490 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Sale of units at initial public offering | 0 |
| 0001213900-25-029490 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Sale of units at initial public offering (in Shares) | 0 |
| 0001213900-25-029490 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Sale Of Private Placement Warrants | 0001213900-25-029490 | Sale of 2,457,000 private placement warrants | 0 |
| 0001213900-25-029490 | 5 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | Fair Value of public warrants at issuance | 0 |
| 0001213900-25-029490 | 5 | 17 | EQ | 0 | H | Adjustments To Additional Paid In Capital Mark To Market | us-gaap/2024 | Fair value of rights included in public units | 0 |
| 0001213900-25-029490 | 5 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | Allocated value of transaction costs to Common Stock | 1 |
| 0001213900-25-029490 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Value I Representative Shares Value | 0001213900-25-029490 | Issuance of Representative Shares | 0 |
| 0001213900-25-029490 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Shares Acquisitions | us-gaap/2024 | Issuance of Representative Shares (in Shares) | 0 |
| 0001213900-25-029490 | 5 | 21 | EQ | 0 | H | Temporary Equity Accretion To Redemption Value Adjustment | us-gaap/2024 | Remeasurement of Common Stock subject to possible redemption | 0 |
| 0001213900-25-029490 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation Forfeited | us-gaap/2024 | Forfeiture of Founder Shares | 0 |
| 0001213900-25-029490 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation Forfeited | us-gaap/2024 | Forfeiture of Founder Shares (in Shares) | 1 |
| 0001213900-25-029490 | 5 | 24 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0001213900-25-029490 | 5 | 25 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001213900-25-029490 | 5 | 26 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
| 0001213900-25-029490 | 6 | 1 | EQ | 1 | H | Sale Of Stock Number Of Private Placement Warrants | 0001213900-25-029490 | Sale of private placement warrants | 0 |
| 0001213900-25-029490 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001213900-25-029490 | 7 | 4 | CF | 0 | H | Other Noncash Expense | us-gaap/2024 | Payment of office expenses made by sponsor | 0 |
| 0001213900-25-029490 | 7 | 5 | CF | 0 | H | Amortization Of Debt Discount Premium | us-gaap/2024 | Courtesy discount on legal fees | 0 |
| 0001213900-25-029490 | 7 | 6 | CF | 0 | H | Change In Fair Value Of Overallotment Option Liability | 0001213900-25-029490 | Change in fair value of Overallotment liability | 0 |
| 0001213900-25-029490 | 7 | 7 | CF | 0 | H | Investment Income Interest | us-gaap/2024 | Interest earned on marketable securities held in Trust Account | 1 |
| 0001213900-25-029490 | 7 | 9 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current asset | 1 |
| 0001213900-25-029490 | 7 | 10 | CF | 0 | H | Increase Decrease In Prepaid Insurance | us-gaap/2024 | Short-term prepaid insurance | 1 |
| 0001213900-25-029490 | 7 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001213900-25-029490 | 7 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001213900-25-029490 | 7 | 13 | CF | 0 | H | Increase Decrease In Accrued Offering Costs | 0001213900-25-029490 | Accrued offering cost | 0 |
| 0001213900-25-029490 | 7 | 14 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Income taxes payable | 0 |
| 0001213900-25-029490 | 7 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001213900-25-029490 | 7 | 17 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2024 | Investment of cash into trust Account | 1 |
| 0001213900-25-029490 | 7 | 18 | CF | 0 | H | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001213900-25-029490 | Cash withdrawn from Trust Account to pay franchise and income taxes | 0 |
| 0001213900-25-029490 | 7 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001213900-25-029490 | 7 | 21 | CF | 0 | H | Proceeds From Issuance Initial Public Offering | us-gaap/2024 | Proceeds from sale of Units, net of underwriting discounts paid | 0 |
| 0001213900-25-029490 | 7 | 22 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from promissory note - related party | 0 |
| 0001213900-25-029490 | 7 | 23 | CF | 0 | H | Proceeds From Notes Payable | us-gaap/2024 | Proceeds from promissory note | 0 |
| 0001213900-25-029490 | 7 | 24 | CF | 0 | H | Proceeds From Bank Debt | us-gaap/2024 | Proceeds from loan payable | 0 |
| 0001213900-25-029490 | 7 | 25 | CF | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Proceeds from sale of private placements warrants | 0 |
| 0001213900-25-029490 | 7 | 26 | CF | 0 | H | Proceeds From Repayments Of Related Party Debt | us-gaap/2024 | Repayment of promissory note - related party | 0 |
| 0001213900-25-029490 | 7 | 27 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payment of offering costs | 1 |
| 0001213900-25-029490 | 7 | 28 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001213900-25-029490 | 7 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net Change in Cash and cash equivalents | 0 |
| 0001213900-25-029490 | 7 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents Beginning of period | 0 |
| 0001213900-25-029490 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents End of period | 0 |
| 0001213900-25-029490 | 7 | 33 | CF | 0 | H | Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-029490 | Remeasurement of Common Stock subject to possible redemption | 0 |
| 0001213900-25-029490 | 7 | 34 | CF | 0 | H | Other Underwriting Expense | us-gaap/2024 | Deferred underwriting fee payable | 0 |
| 0001213900-25-029490 | 7 | 35 | CF | 0 | H | Issuance Of Representative Shares | 0001213900-25-029490 | Issuance of representative shares | 0 |
| 0001213900-25-029490 | 7 | 36 | CF | 0 | H | Stock Issued1 | us-gaap/2024 | Issuance of founder shares | 0 |
| 0001213900-25-029490 | 7 | 37 | CF | 0 | H | Offering Costs Included In Accrued Offering Costs | 0001213900-25-029490 | Offering costs included in accrued offering costs | 0 |
| 0001213900-25-029490 | 7 | 38 | CF | 0 | H | Offering Costs Paid Via Promissory Notes | 0001213900-25-029490 | Offering costs paid via promissory notes | 0 |
| 0001213900-25-031576 | 2 | 8 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash | 0 |
| 0001213900-25-031576 | 2 | 9 | BS | 0 | H | Other Prepaid Expense Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-031576 | 2 | 11 | BS | 0 | H | Assets Current | us-gaap/2024 | Total Current Assets | 0 |
| 0001213900-25-031576 | 2 | 12 | BS | 0 | H | Marketable Securities Noncurrent | us-gaap/2024 | Marketable securities held in Trust Account | 0 |
| 0001213900-25-031576 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001213900-25-031576 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001213900-25-031576 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001213900-25-031576 | 2 | 18 | BS | 0 | H | Accrued Offering Costs Current | 0001213900-25-031576 | Accrued offering costs | 0 |
| 0001213900-25-031576 | 2 | 19 | BS | 0 | H | Taxes Payable Current | us-gaap/2024 | Income taxes payable | 0 |
| 0001213900-25-031576 | 2 | 20 | BS | 0 | H | Overallotment Liability | 0001213900-25-031576 | Overallotment liability | 0 |
| 0001213900-25-031576 | 2 | 21 | BS | 0 | H | Loans Payable Current | us-gaap/2024 | Loan payable | 0 |
| 0001213900-25-031576 | 2 | 22 | BS | 0 | H | Other Notes Payable Current | us-gaap/2024 | Promissory note | 0 |
| 0001213900-25-031576 | 2 | 23 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Promissory note related party | 0 |
| 0001213900-25-031576 | 2 | 24 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
| 0001213900-25-031576 | 2 | 25 | BS | 0 | H | Deferred Underwriting Fee Payable | 0001213900-25-031576 | Deferred underwriting fee payable | 0 |
| 0001213900-25-031576 | 2 | 26 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001213900-25-031576 | 2 | 27 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and Contingencies (Note 5) | 0 |
| 0001213900-25-031576 | 2 | 28 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Common stock subject to possible redemption, 6,900,000 shares at redemption value of $10.41 and $10.00 per share as of December 31, 2024 and 2023, respectively | 0 |
| 0001213900-25-031576 | 2 | 30 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 |
| 0001213900-25-031576 | 2 | 31 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value; 50,000,000 shares authorized, 1,967,000 and 1,999,200 shares issued and outstanding (excluding 6,900,000 shares subject to possible redemption) as of December 31, 2024 and 2023, respectively | 0 |
| 0001213900-25-031576 | 2 | 32 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001213900-25-031576 | 2 | 33 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001213900-25-031576 | 2 | 34 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders Deficit | 0 |
| 0001213900-25-031576 | 2 | 35 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders Deficit | 0 |
| 0001213900-25-031576 | 3 | 1 | BS | 1 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Common stock subject to possible redemption, shares at redemption value | 0 |
| 0001213900-25-031576 | 3 | 2 | BS | 1 | H | Temporary Equity Redemption Price Per Share | us-gaap/2024 | Common stock subject to possible redemption, shares at redemption value per share (in Dollars per share) | 0 |
| 0001213900-25-031576 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock par value (in Dollars per share) | 0 |
| 0001213900-25-031576 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001213900-25-031576 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001213900-25-031576 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-031576 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-031576 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001213900-25-031576 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001213900-25-031576 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001213900-25-031576 | 4 | 7 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Formation and operational costs | 0 |
| 0001213900-25-031576 | 4 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001213900-25-031576 | 4 | 10 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest earned on marketable securities held in Trust Account | 0 |
| 0001213900-25-031576 | 4 | 11 | IS | 0 | H | Change On Overallotment Liability | 0001213900-25-031576 | Change on overallotment liability | 0 |
| 0001213900-25-031576 | 4 | 12 | IS | 0 | H | Lawsuit Settlements | 0001213900-25-031576 | Lawsuit settlements | 0 |
| 0001213900-25-031576 | 4 | 13 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income | 0 |
| 0001213900-25-031576 | 4 | 14 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income (Loss) before provision for income taxes | 0 |
| 0001213900-25-031576 | 4 | 15 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 1 |
| 0001213900-25-031576 | 4 | 16 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0001213900-25-031576 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-031576 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-031576 | 4 | 19 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per common share (in Dollars per share) | 0 |
| 0001213900-25-031576 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per common share (in Dollars per share) | 0 |
| 0001213900-25-031576 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001213900-25-031576 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
| 0001213900-25-031576 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Issuance of founder shares | 0 |
| 0001213900-25-031576 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Issuance of founder shares (in Shares) | 0 |
| 0001213900-25-031576 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Sale of units at initial public offering | 0 |
| 0001213900-25-031576 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Sale of units at initial public offering (in Shares) | 0 |
| 0001213900-25-031576 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Sale Of Private Placement Warrants | 0001213900-25-031576 | Sale of 2,457,000 private placement warrants | 0 |
| 0001213900-25-031576 | 5 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | Fair Value of public warrants at issuance | 0 |
| 0001213900-25-031576 | 5 | 17 | EQ | 0 | H | Adjustments To Additional Paid In Capital Mark To Market | us-gaap/2024 | Fair value of rights included in public units | 0 |
| 0001213900-25-031576 | 5 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | Allocated value of transaction costs to Common Stock | 1 |
| 0001213900-25-031576 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Value I Representative Shares Value | 0001213900-25-031576 | Issuance of Representative Shares | 0 |
| 0001213900-25-031576 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Shares Acquisitions | us-gaap/2024 | Issuance of Representative Shares (in Shares) | 0 |
| 0001213900-25-031576 | 5 | 21 | EQ | 0 | H | Temporary Equity Accretion To Redemption Value Adjustment | us-gaap/2024 | Remeasurement of Common Stock subject to possible redemption | 0 |
| 0001213900-25-031576 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation Forfeited | us-gaap/2024 | Forfeiture of Founder Shares | 0 |
| 0001213900-25-031576 | 5 | 23 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation Forfeited | us-gaap/2024 | Forfeiture of Founder Shares (in Shares) | 1 |
| 0001213900-25-031576 | 5 | 24 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0001213900-25-031576 | 5 | 25 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001213900-25-031576 | 5 | 26 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in Shares) | 0 |
| 0001213900-25-031576 | 6 | 1 | EQ | 1 | H | Sale Of Stock Number Of Private Placement Warrants | 0001213900-25-031576 | Sale of private placement warrants | 0 |
| 0001213900-25-031576 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001213900-25-031576 | 7 | 4 | CF | 0 | H | Other Noncash Expense | us-gaap/2024 | Payment of office expenses made by sponsor | 0 |
| 0001213900-25-031576 | 7 | 5 | CF | 0 | H | Amortization Of Debt Discount Premium | us-gaap/2024 | Courtesy discount on legal fees | 0 |
| 0001213900-25-031576 | 7 | 6 | CF | 0 | H | Change In Fair Value Of Overallotment Option Liability | 0001213900-25-031576 | Change in fair value of Overallotment liability | 0 |
| 0001213900-25-031576 | 7 | 7 | CF | 0 | H | Investment Income Interest | us-gaap/2024 | Interest earned on marketable securities held in Trust Account | 1 |
| 0001213900-25-031576 | 7 | 9 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current asset | 1 |
| 0001213900-25-031576 | 7 | 10 | CF | 0 | H | Increase Decrease In Prepaid Insurance | us-gaap/2024 | Short-term prepaid insurance | 1 |
| 0001213900-25-031576 | 7 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001213900-25-031576 | 7 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001213900-25-031576 | 7 | 13 | CF | 0 | H | Increase Decrease In Accrued Offering Costs | 0001213900-25-031576 | Accrued offering cost | 0 |
| 0001213900-25-031576 | 7 | 14 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Income taxes payable | 0 |
| 0001213900-25-031576 | 7 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001213900-25-031576 | 7 | 17 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2024 | Investment of cash into trust Account | 1 |
| 0001213900-25-031576 | 7 | 18 | CF | 0 | H | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001213900-25-031576 | Cash withdrawn from Trust Account to pay franchise and income taxes | 0 |
| 0001213900-25-031576 | 7 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001213900-25-031576 | 7 | 21 | CF | 0 | H | Proceeds From Issuance Initial Public Offering | us-gaap/2024 | Proceeds from sale of Units, net of underwriting discounts paid | 0 |
| 0001213900-25-031576 | 7 | 22 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from promissory note - related party | 0 |
| 0001213900-25-031576 | 7 | 23 | CF | 0 | H | Proceeds From Notes Payable | us-gaap/2024 | Proceeds from promissory note | 0 |
| 0001213900-25-031576 | 7 | 24 | CF | 0 | H | Proceeds From Bank Debt | us-gaap/2024 | Proceeds from loan payable | 0 |
| 0001213900-25-031576 | 7 | 25 | CF | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Proceeds from sale of private placements warrants | 0 |
| 0001213900-25-031576 | 7 | 26 | CF | 0 | H | Proceeds From Repayments Of Related Party Debt | us-gaap/2024 | Repayment of promissory note - related party | 0 |
| 0001213900-25-031576 | 7 | 27 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payment of offering costs | 1 |
| 0001213900-25-031576 | 7 | 28 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001213900-25-031576 | 7 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net Change in Cash and cash equivalents | 0 |
| 0001213900-25-031576 | 7 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents Beginning of period | 0 |
| 0001213900-25-031576 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents End of period | 0 |
| 0001213900-25-031576 | 7 | 33 | CF | 0 | H | Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-031576 | Remeasurement of Common Stock subject to possible redemption | 0 |
| 0001213900-25-031576 | 7 | 34 | CF | 0 | H | Other Underwriting Expense | us-gaap/2024 | Deferred underwriting fee payable | 0 |
| 0001213900-25-031576 | 7 | 35 | CF | 0 | H | Issuance Of Representative Shares | 0001213900-25-031576 | Issuance of representative shares | 0 |
| 0001213900-25-031576 | 7 | 36 | CF | 0 | H | Stock Issued1 | us-gaap/2024 | Issuance of founder shares | 0 |
| 0001213900-25-031576 | 7 | 37 | CF | 0 | H | Offering Costs Included In Accrued Offering Costs | 0001213900-25-031576 | Offering costs included in accrued offering costs | 0 |
| 0001213900-25-031576 | 7 | 38 | CF | 0 | H | Offering Costs Paid Via Promissory Notes | 0001213900-25-031576 | Offering costs paid via promissory notes | 0 |
| 0001213900-25-043698 | 2 | 3 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash | 0 |
| 0001213900-25-043698 | 2 | 4 | BS | 0 | H | Other Prepaid Expense Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-043698 | 2 | 5 | BS | 0 | H | Prepaid Insurance | us-gaap/2025 | Prepaid insurance | 0 |
| 0001213900-25-043698 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2025 | Total Current Assets | 0 |
| 0001213900-25-043698 | 2 | 7 | BS | 0 | H | Marketable Securities Noncurrent | us-gaap/2025 | Marketable securities held in Trust Account | 0 |
| 0001213900-25-043698 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2025 | Total Assets | 0 |
| 0001213900-25-043698 | 2 | 11 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-043698 | 2 | 12 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001213900-25-043698 | 2 | 13 | BS | 0 | H | Accrued Offering Costs Current | 0001213900-25-043698 | Accrued offering costs | 0 |
| 0001213900-25-043698 | 2 | 14 | BS | 0 | H | Taxes Payable Current | us-gaap/2025 | Income taxes payable | 0 |
| 0001213900-25-043698 | 2 | 15 | BS | 0 | H | Loans Payable Current | us-gaap/2025 | Loan payable | 0 |
| 0001213900-25-043698 | 2 | 16 | BS | 0 | H | Notes Payable Current | us-gaap/2025 | Promissory note | 0 |
| 0001213900-25-043698 | 2 | 17 | BS | 0 | H | Promissory Note Related Party | 0001213900-25-043698 | Promissory note related party | 0 |
| 0001213900-25-043698 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total Current Liabilities | 0 |
| 0001213900-25-043698 | 2 | 19 | BS | 0 | H | Deferred Underwriting Fee Payable | 0001213900-25-043698 | Deferred underwriting fee payable | 0 |
| 0001213900-25-043698 | 2 | 20 | BS | 0 | H | Liabilities | us-gaap/2025 | Total Liabilities | 0 |
| 0001213900-25-043698 | 2 | 21 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and Contingencies (Note 5) | 0 |
| 0001213900-25-043698 | 2 | 22 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2025 | Common stock subject to possible redemption, 6,900,000 shares at redemption value of $10.52 and $10.41 per share as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001213900-25-043698 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 |
| 0001213900-25-043698 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.0001 par value; 50,000,000 shares authorized, 1,967,000 shares issued and outstanding (excluding 6,900,000 shares subject to possible redemption) as of March 31, 2025 and December 31, 2024 | 0 |
| 0001213900-25-043698 | 2 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-043698 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-043698 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total Stockholders Deficit | 0 |
| 0001213900-25-043698 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total Liabilities and Stockholders Deficit | 0 |
| 0001213900-25-043698 | 3 | 1 | BS | 1 | H | Temporary Equity Shares Outstanding | us-gaap/2025 | Common stock subject to possible redemption, shares at redemption value | 0 |
| 0001213900-25-043698 | 3 | 2 | BS | 1 | H | Temporary Equity Redemption Price Per Share | us-gaap/2025 | Common stock subject to possible redemption, shares at redemption value per share (in Dollars per share) | 0 |
| 0001213900-25-043698 | 3 | 3 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock par value (in Dollars per share) | 0 |
| 0001213900-25-043698 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized | 0 |
| 0001213900-25-043698 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued | 0 |
| 0001213900-25-043698 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-043698 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-043698 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-043698 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-043698 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-043698 | 4 | 7 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2025 | Formation and operational costs | 0 |
| 0001213900-25-043698 | 4 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001213900-25-043698 | 4 | 10 | IS | 0 | H | Change In Fair Value Of Overallotment Option Liability | 0001213900-25-043698 | Change in fair value of over-allotment option liability | 0 |
| 0001213900-25-043698 | 4 | 11 | IS | 0 | H | Gain On Lawsuit Settlements | 0001213900-25-043698 | Gain on lawsuit settlements | 0 |
| 0001213900-25-043698 | 4 | 12 | IS | 0 | H | Investment Income Interest | us-gaap/2025 | Interest earned on marketable securities held in Trust Account | 0 |
| 0001213900-25-043698 | 4 | 13 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other income | 0 |
| 0001213900-25-043698 | 4 | 14 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Income before provision for income taxes | 0 |
| 0001213900-25-043698 | 4 | 15 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 1 |
| 0001213900-25-043698 | 4 | 16 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001213900-25-043698 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Basic weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-043698 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Diluted weighted average shares outstanding (in Shares) | 0 |
| 0001213900-25-043698 | 4 | 19 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Basic net income per common share (in Dollars per share) | 0 |
| 0001213900-25-043698 | 4 | 20 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Diluted net income per common share (in Dollars per share) | 0 |
| 0001213900-25-043698 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-043698 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-043698 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation Forfeited | us-gaap/2025 | Forfeiture of Founder Shares | 1 |
| 0001213900-25-043698 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation Forfeited | us-gaap/2025 | Forfeiture of Founder Shares (in Shares) | 1 |
| 0001213900-25-043698 | 5 | 13 | EQ | 0 | H | Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-043698 | Remeasurement of Common Stock subject to possible redemption | 0 |
| 0001213900-25-043698 | 5 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001213900-25-043698 | 5 | 15 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001213900-25-043698 | 5 | 16 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in Shares) | 0 |
| 0001213900-25-043698 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net income | 0 |
| 0001213900-25-043698 | 6 | 4 | CF | 0 | H | Investment Income Interest | us-gaap/2025 | Interest earned on marketable securities held in Trust Account | 1 |
| 0001213900-25-043698 | 6 | 5 | CF | 0 | H | Change In Fair Value Of Overallotment Option Liability | 0001213900-25-043698 | Change in fair value of overallotment liability | 1 |
| 0001213900-25-043698 | 6 | 7 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses | 1 |
| 0001213900-25-043698 | 6 | 8 | CF | 0 | H | Increase Decrease In Prepaid Insurance | us-gaap/2025 | Prepaid insurance | 1 |
| 0001213900-25-043698 | 6 | 9 | CF | 0 | H | Increase Decrease In Due From Related Parties | us-gaap/2025 | Due from Sponsor | 1 |
| 0001213900-25-043698 | 6 | 10 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | Accounts payable and accrued expenses | 0 |
| 0001213900-25-043698 | 6 | 11 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2025 | Income taxes payable | 0 |
| 0001213900-25-043698 | 6 | 12 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001213900-25-043698 | 6 | 14 | CF | 0 | H | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001213900-25-043698 | Cash withdrawn from Trust Account to pay for franchise taxes | 0 |
| 0001213900-25-043698 | 6 | 15 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2025 | Investment of cash into Trust Account | 1 |
| 0001213900-25-043698 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash (used in) provided by investing activities | 0 |
| 0001213900-25-043698 | 6 | 18 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2025 | Proceeds from promissory note related party | 0 |
| 0001213900-25-043698 | 6 | 19 | CF | 0 | H | Proceeds From Notes Payable | us-gaap/2025 | Proceeds from promissory note | 0 |
| 0001213900-25-043698 | 6 | 20 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2025 | Payment of accrued offering costs | 1 |
| 0001213900-25-043698 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by (used in) financing activities | 0 |
| 0001213900-25-043698 | 6 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net Change in Cash | 0 |
| 0001213900-25-043698 | 6 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash Beginning of period | 0 |
| 0001213900-25-043698 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash End of period | 0 |
| 0001213900-25-043698 | 6 | 26 | CF | 0 | H | Remeasurement Of Common Stock Subject To Possible Redemption | 0001213900-25-043698 | Remeasurement of Common Stock subject to possible redemption | 1 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |